Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.950
-0.320 (-7.49%)
At close: Apr 28, 2026, 4:00 PM EDT
4.040
+0.090 (2.28%)
Pre-market: Apr 29, 2026, 8:07 AM EDT
Perspective Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 |
| Market Capitalization | 450 | 204 | 216 | 113 | 35 | 44 | |
| Market Cap Growth | 227.07% | -5.18% | 91.16% | 221.19% | -19.99% | -61.12% | |
| Enterprise Value | 309 | 34 | -48 | 98 | -19 | -14 | |
| Last Close Price | 3.95 | 2.75 | 3.19 | 4.02 | 2.47 | 3.09 | |
| PS Ratio | 509.47 | 231.26 | 148.28 | 78.65 | 6.49 | - | |
| PB Ratio | 1.42 | 0.99 | 0.74 | 1.50 | 0.64 | 0.72 | |
| P/TBV Ratio | 2.70 | 1.22 | 0.90 | 147.82 | 0.64 | 0.72 | |
| EV/Sales Ratio | 349.42 | 38.02 | - | 68.42 | - | - | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.03 | - | 0.01 | |
| Net Debt / Equity Ratio | -0.68 | -0.68 | -0.77 | -0.09 | -0.80 | -0.90 | |
| Net Debt / EBITDA Ratio | 1.28 | 1.28 | 3.46 | 0.17 | 5.16 | 9.02 | |
| Net Debt / FCF Ratio | 1.49 | 1.49 | 3.07 | 0.18 | 4.10 | 6.94 | |
| Asset Turnover | 0.00 | 0.00 | 0.01 | 0.02 | - | - | |
| Quick Ratio | 5.08 | 5.08 | 12.53 | 0.67 | 14.47 | 25.38 | |
| Current Ratio | 5.17 | 5.17 | 12.68 | 1.08 | 17.07 | 26.18 | |
| Return on Equity (ROE) | -41.65% | -41.65% | -42.82% | -57.70% | - | -9.79% | |
| Return on Assets (ROA) | -23.34% | -23.34% | -19.02% | -32.81% | - | -5.95% | |
| Return on Capital Employed (ROCE) | -47.70% | -47.70% | -20.70% | -49.80% | -16.00% | -10.30% | |
| Earnings Yield | -22.90% | -50.44% | -36.77% | -41.23% | -30.64% | -16.57% | |
| FCF Yield | -21.15% | -46.59% | -33.72% | -33.68% | -30.42% | -18.17% | |
| Buyback Yield / Dilution | -14.57% | -14.57% | -140.72% | -88.38% | -0.06% | -36.73% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.